The NBI-‘568-SCZ2028 dose-finding study successfully met its primary endpoint with the once-daily 20 mg dose. This dose showed a significant and clinically meaningful reduction in the Positive and Negative Syndrome Scale (PANSS) total score at Week 6, achieving a placebo-adjusted…
Moderna, Inc. (NASDAQ) has announced the launch of its new awareness initiative, “Do It For You & Them,” aimed at boosting COVID-19 vaccination rates across the United States. This campaign is part of Moderna’s ongoing efforts to address the elevated…
CVS Pharmacy® (NYSE: CVS) has announced that the updated COVID-19 vaccines for the 2024-2025 season, along with flu vaccines, are now available at CVS Pharmacy and MinuteClinic® locations nationwide. Walk-ins are welcome, and the company’s digital vaccine scheduler has been…
Quantum-Si Incorporated (Nasdaq: QSI), known as “The Protein Sequencing Company™,” has announced key leadership appointments. Effective September 17, 2024, Todd Bennett will join the company as the new Chief Commercial Officer. Additionally, John Vieceli, Ph.D., has been named Chief Product…
The new report, “Pharmaceutical Processing and Packaging Equipment Market: Size, Share, Forecast, and Trends Analysis by Formulation, Secondary Packaging, and End-of-Line Packaging – Global Forecast to 2031,” is now available on ResearchAndMarkets.com. The global pharmaceutical processing and packaging equipment market…
Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), a leader in interventional oncology specializing in the treatment of primary and metastatic liver cancers, has announced the publication of an independent study in the European Society for Medical Oncology’s journal…
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that 20 abstracts related to Dupixent® (dupilumab) and the investigational therapy itepekimab will be presented at the European Respiratory Society (ERS) Congress 2024, taking place from September 7 to 11 in Vienna, Austria.…
Viatris Inc. (NASDAQ: VTRS), a leading global healthcare company, today presented results from its Phase 2 study of cenerimod (ACT-333441) as a late-breaking abstract at the 26th Asia-Pacific League of Associations for Rheumatology (APLAR) Annual Congress, held from August 21-25,…
Elanco Animal Health Incorporated (NYSE: ELAN) has announced a significant expansion of its biologics manufacturing facility in Elwood, Kansas. The 25,000-square-foot expansion represents a $130 million investment that will be carried out through 2026, aimed at bolstering the company’s monoclonal…
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced its commitment to supporting the global response to the mpox health emergency by providing diagnostic tests specifically developed for mpox, formerly known as monkeypox. The World Health Organization (WHO) declared mpox a Public…
AbbVie (NYSE: ABBV) has announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy for adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) after two or more lines of prior therapy.…
UptimeHealth, a leader in healthcare technology solutions, is excited to announce a strategic partnership with Darby Dental Supply, a top dental distributor in the U.S. This collaboration introduces Darby Dispatch, a new tool designed to enhance operational efficiency and compliance…
